Key Takeaway: Alvotech has scheduled its annual general meeting for June 3, 2026, in Luxembourg. All proposals on the agenda were unanimously approved during the meeting. Detailed minutes and voting results will be made available on the company's investor relations website.
Price reaction · baseline $3 (2026-06-02 close) · hit after-hours · 4 other ALVO headline(s) in the window, move may be shared
day 0 close · peak
+4.7%
Market Sentiment Analysis
POSITIVE FACTORS
Alvotech's annual general meeting is scheduled for June 3, 2026.
All proposals on the agenda were approved.
The meeting was held at a reputable location in Luxembourg.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+128%
120-day peak, hindsight
Typical move
13.8%
average across 7 past catalysts
Lead asset
Stelara
Phase 3 · Psoriasis
Full Press Release Details
Aðalfundur Alvotech fór fram 3. júní 2026. Fundurinn var haldinn í Lúxemborg, á skrifstofu lögfræðistofunnar Arendt við Avenue John F. Kennedy 41A.